knowledge -WSS

knowledge

author：fashion 2025-09-27 12:34:39 - browse：2478

The home health industry lobbying group is suing Medicare over new payment cuts. But profits in the sector remain near all-time highs. Business Insider/AP

The National Association of Home Care and Hospice sued the Biden administration to halt the government’s recent proposed rule that would cut Medicare payments to home health agencies by 2.2% in 2024.

Since 2020, Medicare has updated its system for how it pays for home health, in particular by basing payments less on how much therapy someone is getting at home. By law, the new system can’t cost more or less than it otherwise would have, but Medicare reinforced this year that it had “paid more under the new system than it would have under the old system” — and thus continued cuts to home health for next year.

Newsletters

Sign up for STAT Health Care Inc.

Following the flow of money through the health care industry.

Please enter a valid email address. Privacy Policy

NAHC, the home health industry’s lobbying group, said in its lawsuit that Medicare has been violating the requirement to keep things “budget-neutral” and threatens to put home health operators out of business. But one thing NAHC failed to mention: Profits in the home health industry remain near all-time highs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： FDA does about

hotspot

WSS

UCB departs biotech trade group BIO

Feng Zhang, Grail founder join forces on new gene editing startup

JPM: CVS says Medicare Advantage patients are impacting profits

FogPharma raises $145 million in rare Series E round

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

How to fix the rural physician shortage in the U.S.

focus

knowledge

Sign up for STAT Health Care Inc.

entertainment

Drug repurposing or repositioning? The language matters

JPM: CVS says Medicare Advantage patients are impacting profits

Medical leaders decry Supreme Court decision on affirmative action

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Tori Bowie and the unacceptable rates of Black maternal death

Burning questions for the 2024 JPM Healthcare Conference

Continuity nursing helped my family in our darkest PICU moments

The biotech scorecard for Q1: 17 stock

Malaria cases in Florida and Texas: Here’s what you need to know

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

knowledge

ALS groups 'won't be played again' by the FDA, drug sponsors

How to address the problem of discarded donor organs

Insitro, AI biotech unicorn, brings cash, new research to JPM 2024

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

House looks to weaken Medicare negotiation

GSK Flovent asthma inhalers replaced by authorized generics

focus

hotspot

hotspot

hotspot